期刊文献+

海洋甾体(25R)-胆甾-3β,5α,6β,26-四醇的合成及生物活性研究

Synthesis and Bioactivities of Marine Sterol(25R)-Cholest-3β,5α,6β,26-Tetrol
原文传递
导出
摘要 目的设计合成天然产物(25R)-胆甾-3β,5α,6β,26-四醇,并评价其抗胶质瘤活性。方法以薯蓣皂素为原料,经过Zn-Hg齐还原开环,叔丁基二甲基氯硅烷(TBDMSCl)保护C-3、C-26羟基,甲基磺酰氯(MsCl)磺酰酯化C-16羟基,LiAlH4还原C-16甲基磺酸酯,间氯过氧苯甲酸(mCPBA)氧化5,6位双键,酸性条件下开环、脱保护反应得到(25R)-胆甾-3β,5α,6β,26-四醇;并通过MTT法对该化合物的抗胶质瘤活性进行了初步研究。结果各中间体和目标化合物通过1H-NMR、13C-NMR、IR、EI-MS、EA等现代波谱技术进行了结构表征;化合物在浓度为10~150μg.mL-1时,胶质瘤细胞的生存率存在显著性差异,其IC50为51.57μg.mL-1。结论利用廉价易得的薯蓣皂素合成了一种天然海洋甾体,该目标化合物具有显著的抗胶质瘤活性,且具有浓度依赖性,值得进一步研究。 OBJECTIVE To synthesize a marine sterol(25R)-cholestane-3β,5α,6β,26-tetrol and to investigate its anti-glioma activity.METHODS Starting from commercially available diosgenin,(25R)-5α-cholest-5-en-3β,16β,26-triol was first synthesized by reduction with Zn amalgam;then(25R)-3,26-di(t-butyldimethylsilyloxy)-5α-cholest-5-en-3β,26-diol was synthesized by protection with TBDMSCl,methyl sulfonylation with MsCl and elimination with LiAlH4;finally,the aimed compound was obtained by oxidation of mCPBA and hydroxylation.Its anti-glioma activity was investigated by MTT method.RESULTS The aimed compound and its intermediates were characterized by 1H-NMR,13C-NMR spectra,IR EI-MS and EA.The effective inhibiting concentrations ranges were 10-150 μg·mL-1,and the IC50 was 51.57 μg·mL-1.CONCLUSION The study has established a synthetic method for marine sterol which can significantly suppress the growth of MGR2 malignant glioma cells in a concentration-dependent manner.
出处 《中国药学杂志》 CAS CSCD 北大核心 2011年第18期1447-1451,共5页 Chinese Pharmaceutical Journal
基金 国家自然科学基金资助项目(30472089)
关键词 薯蓣皂素 (25R)-胆甾-3β 26-四醇 抗胶质瘤活性 diosgenin 25(R)-cholest-3β 26-tetrol anti-glioma activity
  • 相关文献

参考文献1

二级参考文献10

  • 1Hutchins,R.O.,Taffer,I.M.,Burgoyne,W. Journal of Organic Chemistry . 1981
  • 2Syamala, M. S,Das J,Baskaran S,Chandracekaran S.A novel and highly beta-selective epoxidation of DELTA 5-unsaturated steroids with permanganate ion[].Journal of Organic Chemistry.1992
  • 3Karen,S Moore,Suzanne,W,Heinrich,R,Mark,R,John,N,Forrest,Jr.D.M,Michael,Z. Proc.Nati.Acad.Sci . 1993
  • 4Sills, A. K Jr.,Williams, J. I.,Tyler, B. M.,Epstein, D. S.,Sipos, E. P.,Davis, J. D.,McLane, M. P,Pitchford, S.,Cheshire, K.,Gannon, F. H.,Kinney, W. A.,Chao. T. L.,Donowitz, M.,Laterra. J.,Zasloff, M.,Brem, H. Cancer Research . 1998
  • 5Pechulis, A. D,Bellevuell, C. L. C,Trapp, S. G,Fojtik,J. P,McKitty, A. A,Frye, L. L. Journal of Organic Chemistry . 1995
  • 6Zhang, X. H,Rao, M. N,Jones, S. R,Shao, B,Feibush, P,McGuigan, M,Tzodikov, N,Feibush, B,Sharkansky, I,Snyder, B,Mallis, L. M,Sarkahian, A,Wilder, S,Turse, J. E,Kinney, W. A. Journal of Organic Chemistry . 1998
  • 7Jones, S. R,Selinsky, B. S,Rao, M. N,Zhang, X. H,Kinney, W. A,Tham, F. S. Journal of Organic Chemistry . 1998
  • 8Bhargava, P,Marshall, J. L,Dahut, W,Rizvi, N,Trocky, N,Williams, J. I,Hait, H,Song, S,Holroyd, K. J,Hawkins, M. J. Clinical Cancer Research . 2001
  • 9Williams, J. I,Weitman, S,Gonzalez, C. M,Jundt, C.H,Marty, J,Stringer, S. D,Holroyd, K. J,McLane, M. P,Chen, Q,Zasloff, M,Von Hoff, D. D. Clinical Cancer Research . 2001
  • 10Moriarty, R. M,Enache, L. A,Kiney, W. A,Allen, C.S,Canary, J. W,Tuladhar, S. M,Guo, L. Tetrahedron Letters . 1995

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部